TELA Bio faces Nasdaq delisting notice after failing $1 minimum bid rule

TELA Bio received a Nasdaq delisting notice tied to the exchange’s $1 minimum bid rule after the company failed to regain compliance by the end of its 180-day deadline on Sept. 14, 2026.

Nasdaq warned on Sept. 15, 2026 that the shares face delisting unless the company requests a hearing with a Nasdaq Hearings Panel. The planned hearing request would stay any suspension or delisting while the process runs, keeping the stock trading on Nasdaq.

Regaining compliance requires a closing bid of at least $1 for 10 consecutive business days, or up to 20 at Nasdaq’s discretion.

A reverse stock split vote is set for Oct. 8, 2026, with a proposed range of 1-for-5 to 1-for-15.